具有可追溯协同疗法的增强药物负载和反应性氧物种响应释放能力的正电荷多药物两性体
Yan Li1, Yanhui Li1, Weihong Ji1,2
1State Key Laboratory of Biochemical Engineering , Institute of Process Engineering, Chinese Academy of Sciences , Beijing 100190 , China.
Journal of the American Chemical Society
|February 28, 2018
概括
研究人员开发了用于阿尔茨海默病 (AD) 治疗的新型可追溯纳米粒子. 这些纳米粒子提供药物和神经干细胞, 改善记忆缺陷, 实现MRI追踪.
科学领域:
- 生物医学工程
- 纳米技术
- 神经科学
背景情况:
- 由于不同的化学性质,不同疗法 (药物,核酸,纳米颗粒) 的同时输送具有挑战性.
- 现有的载体难以有效地联合封装疏水性和疏水性剂.
- 在神经退行性疾病中开发可追溯的协同疗法仍然是一个重大障碍.
研究的目的:
- 合成带正电荷的多种药物两性分子,以制造可追溯的共递纳米粒子 (NP).
- 通过同时提供药物和神经干细胞 (NSCs) 来实现阿尔茨海默病 (AD) 的协同治疗.
- 使用超偏磁氧化铁纳米立方体 (SPION) 进行磁共振成像 (MRI) 追踪移植的NSC.
主要方法:
- 合成带正电荷的多种药物.
- 在NP中加载疏水性SPION和let-7b反意义寡核酸.
- 在体外评估药物释放和对神经干细胞 (NSC) 的影响.
- 在2xTg-AD小鼠模型和MRI追踪中对NP疗效的体内评估.
主要成果:
- 成功构建可追溯的NP能够同时提供SPION,药物和let-7b反意义寡核酸.
- NPs显示药物释放受控,NSC分化减少,BDNF分泌增强.
- 在2xTg-AD小鼠中,使用NP显著挽救记忆缺陷.
- 在NP中的SPION允许对NSC移植部位和迁移进行MRI跟踪.
结论:
- 具有正电荷的多药基可追溯NP为阿尔茨海默病治疗提供了一个有希望的平台.
- 这种方法有助于协同治疗和实时监测治疗干预.
- 开发的NP具有治疗阿尔茨海默氏症和其他神经退行性疾病的潜力.
相关概念视频
Bioavailability Enhancement: Drug Solubility Enhancement
260
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
260
Bioavailability Enhancement: Drug Permeability Enhancement
205
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
205
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
218
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
218
Drug Therapy
296
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
296
Formal Charges
40.5K
In some cases, there are seemingly more than one valid Lewis structures for molecules and polyatomic ions. The concept of formal charges can be used to help predict the most appropriate Lewis structure when more than one reasonable structure exists.
40.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K


